Show/hide contentOpenClose All
Curricular information is subject to change
On completion of this module, students will be able to:
1. Outline the business environment in which pharmaceutical, biotech and medical device companies operate
2. Explain the principles that guide the management of these companies
3. Describe the process of drug development from a commercial perspective, outline the risks involved, and how new drug products are marketed
4. Describe regulation of key business activities such as marketing and reimbursement of healthcare products and medicines
Student Effort Type | Hours |
---|---|
Lectures | 18 |
Specified Learning Activities | 12 |
Autonomous Student Learning | 70 |
Total | 100 |
Not applicable to this module.
Description | Timing | Component Scale | % of Final Grade | ||
---|---|---|---|---|---|
Assignment: Product Profile (INDIVIDUAL) | Throughout the Trimester | n/a | Graded | Yes | 30 |
Assignment: Business Case Study Report (GROUP) | Coursework (End of Trimester) | n/a | Graded | No | 45 |
Presentation: Presentation of Business Case Study (GROUP) | Coursework (End of Trimester) | n/a | Graded | No | 25 |
Remediation Type | Remediation Timing |
---|---|
In-Module Resit | Prior to relevant Programme Exam Board |
• Feedback individually to students, on an activity or draft prior to summative assessment
• Feedback individually to students, post-assessment
• Peer review activities
Not yet recorded.
Name | Role |
---|---|
Dr Antonio Garzon Vico | Lecturer / Co-Lecturer |
Professor Jan Rosier | Lecturer / Co-Lecturer |